Buyer is solely responsible for determining whether Buyer has all intellectual property rights that are necessary for Buyer's intended uses of the BioLegend TotalSeq™ products. For example, for any technology platform Buyer uses with TotalSeq™, it is Buyer's sole responsibility to determine whether it has all necessary third party intellectual property rights to use that platform and TotalSeq™ with that platform. 

TotalSeq™-B antibodies are designed to be used with 10x Single Cell 3’ Reagent Kit v3 with Feature Barcoding. The adjusted protocol below is for customers who are utilizing TotalSeq™-A antibodies with the v3 kit instead.

Please read the entire protocol below and the 10x Genomics user guide for the Chromium Single Cell 3ʹ Reagent Kits v3 with Feature Barcoding technology for Cell Surface Protein before starting the experiments. 10x Genomics user guide document number CG000206, Rev D.


Commonly used abbreviations:

 

Reagent and Instrument List

For Cell Surface staining:

 

For library preparation:

 

Other essential reagents:

 

Researchers are advised to validate equivalent products when substituting for the above recommendations.

 

Protocol


I) Cell labeling

 

  1. Aliquot 50 µl of cells into 12 x 75mm tubes.  

  2. Add 5 µl of Human TruStain FcX™ Fc, or 0.5 µl of TruStain FcX™ PLUS (anti-mouse CD16/32) Blocking reagent  
    Note: We no longer recommend the use of dextran during blocking/staining. If you have any questions please contact BioLegend Technical Support.

  3. Incubate for 10 min at 4°C.

  4. While cells are incubating in Fc Block, prepare antibody pool using 1 µg (or titrated amounts) of each TotalSeq™ or Biotinylated antibody.  

  5. To maximize performance, centrifuge the antibody pool at 14,000xg at 2 – 8°C for 10 minutes before adding to the cells.
    Note: If antibody cocktail volume is less than 50 µl, add Cell Staining Buffer up to 50 µl, then centrifuge.

  6. Carefully pipette out the liquid, avoiding the bottom of the tube, and add the TotalSeq™ antibody cocktail to the cell suspension.  

  7. Incubate for 30 minutes at 4°C.

  8. Add 3.5 mL of cell staining buffer and spin 5 minutes 400g at 4°C. Repeat wash 2 more times for a total of 3 washes.

  9. If using biotinylated antibodies, incubate with the appropriate oligo barcoded streptavidin at the recommended amount specified in the product technical datasheet for 20 minutes. Then add 3.5mLs of cell staining buffer and spin 5 minutes 400g at 4°C. Repeat wash 2 more times for a total of 3 washes.

  10. Resuspend cells in 500 µL of PBS to get a concentration of 1x106 cells/mL.

  11. Filter cells through 40 µm Flowmi™ Cell Strainer.

  12. Verify cell concentration by counting on hemocytometer after filtration.
    Note: We highly recommend determining cell viability. Ideally the viability should be >90% for optimal capture rate. The presence of a large number of non-viable cells can decrease the efficiency of the cell partitioning and recovery within the 10x Chromium chip.   

  13. Dilute cells as necessary for appropriate input into the 10X Chromium chip.

 

II) Run 10x Genomics single cell 3' v3 assay as described through Post Gem-RT Cleanup – Dynabeads (step 2.1). 10x Genomics Document CG000185, Rev D.

At cDNA amplification step (Step 2.2), use the following table:  

 

  ADT 1 rxn (µl) HTO 1rxn (µl) ADT + HTO 1 rxn (µl)
Amp Mix 50 50 50
cDNA Primers* 15 15 15
ADT Additive Primer (0.2 µM stock) 1 0 1
HTO Additive primer (0.2 uM stock) 0 1 1
Total 66 66 67

* included with 10x Genomics 3’ kit, different from Feature cDNA primers 2.

 

Notes:
 

Follow steps 2.3A and 2.3B exactly to separate ADTs/HTOs from cDNA. Continue to use 70 µL of sparQ or SPRI beads in step 2.3B.
ADT: Antibody derived tags, it refers to regular TotalSeq™-A antibodies
HTO: TotalSeq™-A Hashtag antibodies
See notes at the end of the protocol for further details on primer sequences.

 

III) ADT and mRNA library preparation

For ADT For HTO Volume (µl)
Purified ADT/HTO fraction Purified ADT/HTO fraction 5
SI PCR primer
(10uM stock)
SI PCR primer
(10uM stock)
2.5
TrueSeq Small RNA RPIx (10uM stock) TruSeq D70x_s
(10uM stock)
2.5
2X QuantaBio or Kapa Hifi Master Mix 2X QuantaBio or Kapa Hifi Master Mix 50
RNAse-free water RNAse-free Water 40
  Total 100

 

Note: For samples that contain both ADT and HTO, perform two separate reactions and add 5 µl of “purified ADT/HTO fraction” from the same sample to ADT or HTO reaction.

 

ADT
98°C 2min  
98°C 20sec 14 - 15 Cycles
60°C 30sec
72°C 20sec
72°C 5min  
4°C hold  
HTO
98°C 2min  
98°C 20sec 12 - 13 Cycles
64°C 30sec
72°C 20sec
72°C 5min  
4°C hold  

 

  1. Add 120 µl sparQ or SPRIselect Reagent (1.2X) to each sample.
  2. Incubate 5 min at room temperature.
  3. Place on the magnet in its High position until the solution clears.
  4. Carefully remove and discard the supernatant.
  5. Place tubes on magnet in its High position. Wash pellet twice with 200 µl 80% ethanol.
  6. Centrifuge briefly. Place on the magnet Low. Remove remaining ethanol.
  7. Remove from the magnet. Add 40.5 µl water.
  8. Incubate 2 min at room temperature.
  9. Place on the magnet in its Low position until the solution clears.
  10. Transfer 40 µl to a new tube strip. Store at 4°C for up to 72 h or at −20°C for long-term storage.
  11. ADT/HTO libraries are now ready to be sequenced
    Quantify libraries by standard methods (QuBit, BioAnalyzer, qPCR).     
    ADT libraries will be around 180 bp (Figure 1B).


Sequencing CITE-seq libraries:

We estimate that an average of 100 molecules per ADT per cell is sufficient to achieve useful information. The number of reads required to obtain 100 molecules depends on the complexity of the sequencing library (e.g. duplication rate). ADT and mRNA cDNA sequencing libraries can be pooled at desired proportions. To obtain sufficient read coverage for both libraries, we typically sequence ADT libraries in 5-10% of a lane and cDNA library fraction at 90% of a lane (HiSeq2500 Rapid Run Mode Flowcell) (Approximately 5k reads/cell for ADTs).

 

Notes:

Oligonucleotide sequences:

TotalSeq™ antibodies. Each clone is barcoded with a unique oligonucleotide sequence. These contain standard small TruSeq RNA read 2 sequences and can be amplified using Illumina’s Truseq Small RNA primer sets (RPIx – primers, see example RPI1 below)

CCTTGGCACCCGAGAATTCCAAACAAGACCCTTGAGBAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA*A*A.


Please visit https://www.biolegend.com/totalseq for detailed information:

Oligos required for ADT library amplification:


PAGE purification is the preferred method when ordering primers.
The phosphorothioate bonds in the primer renders the oligonucleotide resistant to nuclease degradation.
A unique Illumina primer (index) should be used for each 10x Genomics sample lane used within one sequencing lane.

 

* indicates a phosphorothioate bond
B indicates C or G or T; not A nucleotide

 

Name

Sequence

Do Not Use with the
10x Genomics Index

SI-PCR primer 

AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC*T*C  

HTO additive primer

GTGACTGGAGTTCAGACGTGTGC*T*C  

ADT additive primer

CCTTGGCACCCGAGAATT*C*C  
 

D701_S

CAAGCAGAAGACGGCATACGAGATCGAGTAATGTGACTGGAGTTCAGACGTGT*G*C  

D702_S

CAAGCAGAAGACGGCATACGAGATTCTCCGGAGTGACTGGAGTTCAGACGTGT*G*C  

D703_S

CAAGCAGAAGACGGCATACGAGATAATGAGCGGTGACTGGAGTTCAGACGTGT*G*C  

D704_S

CAAGCAGAAGACGGCATACGAGATGGAATCTCGTGACTGGAGTTCAGACGTGT*G*C  

D705_S

CAAGCAGAAGACGGCATACGAGATTTCTGAATGTGACTGGAGTTCAGACGTGT*G*C  

D706_S

CAAGCAGAAGACGGCATACGAGATACGAATTCGTGACTGGAGTTCAGACGTGT*G*C  

D707_S

CAAGCAGAAGACGGCATACGAGATAGCTTCAGGTGACTGGAGTTCAGACGTGT*G*C  

D708_S

CAAGCAGAAGACGGCATACGAGATGCGCATTAGTGACTGGAGTTCAGACGTGT*G*C  

D709_S

CAAGCAGAAGACGGCATACGAGATCATAGCCGGTGACTGGAGTTCAGACGTGT*G*C  

D710_S

CAAGCAGAAGACGGCATACGAGATTTCGCGGAGTGACTGGAGTTCAGACGTGT*G*C  

D711_S

CAAGCAGAAGACGGCATACGAGATGCGCGAGAGTGACTGGAGTTCAGACGTGT*G*C

SI-GA-E7

D712_S

CAAGCAGAAGACGGCATACGAGATCTATCGCTGTGACTGGAGTTCAGACGTGT*G*C

SI-GA-A10

 

RPI1

CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCCTTGGCACCCGAGAATTC*C*A  

RPI2

CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCCTTGGCACCCGAGAATTC*C*A  

RPI3

CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGTTCCTTGGCACCCGAGAATTC*C*A  

RPI4

CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCCTTGGCACCCGAGAATTC*C*A  

RPI5

CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGTTCCTTGGCACCCGAGAATTC*C*A  

RPI6

CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCCTTGGCACCCGAGAATTC*C*A  

RPI7

CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTCCTTGGCACCCGAGAATTC*C*A SI-GA-A11

RPI8

CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGTTCCTTGGCACCCGAGAATTC*C*A  

 

Representative Data and Troubleshooting

 

A.
B.

Figure 1. ADT library verification.
(Left graph) A TSO-RT-oligo product (~140 bp) can be amplified during the ADT PCR by carryover primers from cDNA amplification. The product will not cluster but will interfere with quantification. Sequential 2X sparQ or SPRI purification of the ADT fraction after cDNA amplification reduces carryover of primers from cDNA amplification, and minimizes the amplification of this product during ADT-library amplification. To further enrich for ADT specific product the purified ADT library can be reamplified for 3 additional cycles with ADT specific primer sets or P5/P7 generic primers. (Right graph) A clean ADT library will contain a predominant single peak at around 180 bp.


 


Figure 2. My ADT/HTO library contains a large peak at ~400bp
Overamplification of a library can lead to depletion of available primers and/or dNTPs resulting in self-priming of PCR products by their P5 and/or P7 adapters. This can lead to the production of “daisy-chains” or “bubble products”. These products consist of essentially 2 ADT or HTO barcode sequences attached to one another in 1 long oligo tag that is twice as long as the original oligo tag; these products appear as peaks at approximately 400 bp. These peaks can be more or less pronounced (panel A and B respectively).  

The larger peak is perfectly acceptable to sequence. However, it is difficult to quantify these libraries to titrate for sequencing. This error can be corrected by performing another PCR reaction using generic P5/P7 primers (not used in the protocol) for one or two cycles on the 1.2x sparQ or SPRI cleaned up product. The PCR reaction will convert the larger product to the desired size product partially (panel C) or completely (panel D) as the major peak.